Trial intelligence / Profile preview

Food Effect on Estetrol/Drospirenone Bioavailability

NCT02852681Phase 1Completed

Sponsor
Estetra SRL
Start
Aug 2015
Primary completion
Oct 2015
Modality
Small Molecules
01

Overview

Phase 1, randomised, open-label trial of estetrol in contraception (2 arms), sponsored by Estetra SRL. Primary endpoints: Maximum concentration of estetrol in plasma, Maximum concentration of drospirenone in plasma and 4 more. Started Aug 2015; status: completed.

02

Drugs

estetrol
03

Conditions

contraception

Beyond the preview

Go deeper on NCT02852681.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02852681.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call